ICFG Hong-Kong, China successfully advised Alpha Fine Chemicals on its latest funding round
Valentin is an Executive Director in the Investment Banking Team of ICFG Hong-Kong, China (CIGP Group). He is fluent in French, English, German and conversational in Mandarin.
Valentin is responsible for the sourcing and execution of advisory transactions, where he regularly advises our Group’s clients on cross-border M&A transactions, as well as in the context of refinancing and restructuring situations.
He also contributed to design CIGP’s e-Platform, which gives our clients and partners mobile access to our services.
Prior to joining CIGP Group, Valentin worked in the investment banking industry in Zurich for Credit Suisse, where he was a derivatives trader in the Bank’s Global Financing Group. His role involved providing leverage against concentrated portfolios, single stock positions, and various other illiquid financial assets in the context of Pre-IPO financings and leveraged buyouts.
Valentin is a Licensed Representative registered with the Hong Kong Securities and Futures Commission.
Valentin attended the University of Hong Kong and HEC Lausanne, graduating with a Master’s degree in financial engineering and a Bachelor’s degree in management.
ICFG Hong-Kong, China successfully advised Alpha Fine Chemicals on its latest funding round
ICFG China, based in Hong-Kong, CIGP, recently entered into exclusive negotiations with regards to a US$70 million project finance facility with KfW IPEX – Bank and is expecting to reach financial close in the course of this year, subject to customary confirmatory due-diligence.
ICFG China advises Alliance Pharma on the sale of a majority stake to Zuellig Pharma
| ICFG member CIGP, based in Hong Kong, has advised the shareholders of Alliance Pharma (Cambodge), a leading healthcare and consumer health products distributor in Cambodia, on the sale of a majority stake to Zuellig Pharma, a leading healthcare services provider in Asia, headquartered in Singapore. |
